---
title: O.C.G.A. § 26-4-6. Provisions of chapter not applicable to facilities engaged solely in distribution of dialysate drugs or certain dialysis equipment under certain conditions.
collection: code
id: 26-4-6
cite_as: O.C.G.A. § 26-4-6 (2025)
canonical_url: https://georgiacommons.org/code/26-4-6
md_url: https://georgiacommons.org/code/26-4-6.md
text_url: https://georgiacommons.org/code/26-4-6/text
source_url: https://www.legis.ga.gov/api/document/docs/default-source/joint-features-document-library/t24-t26-(v21)-2023-pdf.pdf?sfvrsn=5423edd_0#page=498
date: 2025
status: active
corpus_version: 2025-supplement-89aa39ab3c68
license: CC0-1.0
publisher: Georgia Commons, an independent project of Georgia Civic Data. Not the State of Georgia. Not legal advice.
up: https://georgiacommons.org/code/26-4.md
previous: https://georgiacommons.org/code/26-4-5.md
next: https://georgiacommons.org/code/26-4-20.md
index: https://georgiacommons.org/code/index.md
version: the only printed version
in_force: true
current_through: Including Acts of the 2025 Regular Session of the General Assembly
heading_path: FOOD, DRUGS, AND COSMETICS / PHARMACISTS AND PHARMACIES / GENERAL PROVISIONS
---

# O.C.G.A. § 26-4-6. Provisions of chapter not applicable to facilities engaged solely in distribution of dialysate drugs or certain dialysis equipment under certain conditions.

The provisions of this chapter shall not apply to a facility engaged solely in the distribution of dialysate drugs, or devices necessary to perform home kidney dialysis to patients with end stage renal disease, provided that the following criteria are met:

(1) The dialysate drugs, or devices are approved or cleared by the federal Food and Drug Administration as required by federal law;

(2) The dialysate drugs, or devices are lawfully held by a manufacturer or manufacturer’s agent that is properly registered with the board as a manufacturer or wholesale distributor;

(3) The dialysate drugs, or devices are held and delivered in their original, sealed packaging from the manufacturing facility;

(4) The dialysate drugs, or devices are delivered only by the manufacturer or the manufacturer’s agent and only upon receipt of a physician’s order; and

(5) The manufacturer or manufacturer’s agent delivers the dialysate drugs, or devices directly to:

(A) A patient with end stage renal disease or such patient’s designee for the patient’s self-administration of the dialysis therapy; or

(B) A health care provider or institution for administration or delivery of the dialysis therapy to a patient with end stage renal disease.

## History

Code 1981, § 26-4-6, enacted by Ga. L. 2015, p. 585, § 2/SB 194.